BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

For several years, per capita expenditure

Expert replies
by aspirant2011 » Tue May 03, 2011 9:30 am
For several years, per capita expenditure on prescription drugs in Voronia rose by fifteen percent or more annually. In order to curb these dramatic increases, the ministry of health prohibited drug manufacturers from raising any of their products' prices. Even though use of prescription drugs did not expand after this price freeze, per capita expenditure for prescription drugs continued to increase by a substantial percentage each year.

Which of the following, if true, most helps to explain why the ministry's action did not achieve its goal?

A. After price increases were prohibited, drug manufacturers concentrated on producing new medications to replace existing products.
B. The population of Voronia rose steadily throughout the period.
C. Improvements in manufacturing processes enabled drug manufacturers to maintain high profit levels on drugs despite the price freeze.
D. In addition to imposing a price freeze, the government encouraged doctors to prescribe generic versions of common drugs instead of the more expensive brand-name versions.
E. After price increases were prohibited, some foreign manufacturers of expensive drugs ceased marketing them in Voronia.

[spoiler]OA: A vs C.....which one is better and why???Plz justify your reasoning[/spoiler]
Join the discussion
Source: — Critical Reasoning |

by finance » Tue May 03, 2011 10:11 am
I would go for A. A because it provides a possible explanation why capital expenditures would increase, whereas C does not explain straight forward the reason of increase. C seems to me shifting from the focus of the question.
Join the discussion

by HSPA » Tue May 03, 2011 5:42 pm
gross exp = total exp/ total population = exp per person

gross exp is incresing even though total exp is remained constant.
How is A helping in resolving this...
I am very bad at macro economics... Kindly help
First take: 640 (50M, 27V) - RC needs 300% improvement
Second take: coming soon..
Regards,
HSPA.
Join the discussion

by finance » Wed May 04, 2011 1:39 am
HSPA wrote:gross exp = total exp/ total population = exp per person

gross exp is incresing even though total exp is remained constant.
How is A helping in resolving this...
I am very bad at macro economics... Kindly help
Well, capital expenditure is the amount that customers spend on drugs, isn't it? The price freezes, but the capital expenditure keeps increasing due to prescription of the new substitutes. I thought that customers would still keep buying medications, but this time the new ones. Even though, I solved it by removing the other options first.
Join the discussion

by GMATMadeEasy » Wed May 04, 2011 2:37 am
@HSPA:
How is A helping in resolving this...
P1: Price freeze for the products P2: No increase in demand C: Still increased proportion in per capita expenditure for the drugs under discussion

Normally,this should not have been the case. Something these companies must have done to raise their profits . Look at A now

A -> After price increases were prohibited, drug manufacturers concentrated on producing new medications to replace existing products.

These clever folks found a way to deal with government by replacing the existing medicine that were under price freeze by new medicines that would not fall under the price freeze. hence allowing companies to raise the price , resulting in more expenditure per capita.
Join the discussion